Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis
Sponsor: Peking University First Hospital
Summary
The goal of this real-world prospective diagnostic study is to comprehensively evaluate the value of MRI artificial intelligence (MRI-AI) in assisting the diagnosis of prostate cancer (PCa). The main questions it aims to answer are: Does MRI-AI promote the accurate diagnosis and treatment of prostate cancer? What's the capability of prostate MRI-AI in calculating the prostate volumn? What's the value of prostate MRI-AI assistant diagnosis system in detecting the suspicious lesions on MRI and guiding prostate targeted biopsy? What's the value of prostate MRI-AI assistant diagnosis system in predicting the pathological results of prostate targeted biopsy? Researchers will compare the cancer detection rates of suspicious lesions detected by MRI-AI and senior radiologists. Participants will: Receive combination of systematic biopsy and targeted biopsy.
Official title: Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis: a Real-World Prospective Diagnostic Study
Key Details
Gender
MALE
Age Range
45 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
365
Start Date
2024-01-01
Completion Date
2025-08-31
Last Updated
2026-05-06
Healthy Volunteers
No
Conditions
Interventions
Combination of targeted biopsy and systematic biopsy
Before prostate biopsy, the MR images of patients were independently reviewed by MRI-AI and urogenital radiologists. Then the images with suspicious lesions highlighted by MRI-AI and urogenital radiologists. Urologists conducted targeted biopsies for all suspicious lesions and systematic biopsies. Biopsies were performed under the guidance of transrectal ultrasound (TRUS) through the transrectal or transperineal route.
Locations (1)
Peking University First Hospital
Beijing, Beijing Municipality, China